CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 

Cumulative Amgen Inc 's Working Capital Ratio for Trailing Twelve Months Period

AMGN's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

AMGN Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth -3.44 % -13.49 % 0.13 % 4.56 % 49.12 %
Y / Y Current Assets Growth -1.3 % 1.17 % -13.05 % -8.32 % 7.59 %
Working Capital Ratio for Trailing Twelve Months Period 1.56 1.55 1.49 1.54 1.59
Total Ranking # 2501 # 3068 # 3245 # 3346 # 2582
Seq. Current Liabilities Growth 13.58 % -2.08 % 5.76 % -17.91 % 1.76 %
Seq. Current Assets Growth 24.53 % 4.33 % -4.46 % -20.49 % 27.65 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Current Liabilities decreased faster than Amgen Inc 's average Current Assets, this led to increase in in Amgen Inc 's Working Capital Ratio for Trailing Twelve Months Period to 1.56, Working Capital Ratio for Trailing Twelve Months Period remained below Amgen Inc average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 230 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Amgen Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 2501, from total ranking in previous quarter at 3068.

What is Working Capital Ratio?
More about AMGN
Working Capital Ratio AMGN in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 231
Sector # 876
S&P 500 # 2498


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.46 3.32 1.49
(Dec 31 2017)   (Mar 31 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Working Capital Ratio for Trailing Twelve Months Period
Genfit S a   4.27 
Atara Biotherapeutics Inc   4.20 
X4 Pharmaceuticals Inc  4.17 
Biocardia Inc  4.14 
Windtree Therapeutics Inc  4.13 
Establishment Labs Holdings Inc   4.11 
Xtant Medical Holdings Inc   4.11 
Biomerica Inc   4.00 
Natural Health Trends Corp   3.87 
Meridian Bioscience Inc   3.87 
Regenxbio Inc   3.85 
Bio techne Corp  3.80 
Myomo Inc   3.75 
Idera Pharmaceuticals Inc   3.72 
Denali Therapeutics Inc   3.69 
Quotient Limited  3.58 
Axcella Health Inc   3.55 
Kiromic Biopharma Inc   3.54 
Casi Pharmaceuticals inc   3.51 
Molecular Partners Ag  3.50 
Edwards Lifesciences Corporation  3.47 
Lucira Health Inc   3.46 
Central Garden and Pet Co  3.40 
Sanara Medtech Inc   3.40 
Cue Health Inc   3.38 
Standard Biotools Inc   3.37 
Avanos Medical Inc   3.29 
Champions Oncology Inc   3.17 
Oncocyte Corporation  3.16 
Neurocrine Biosciences Inc   3.15 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

STXS's Profile

Stock Price

STXS's Financials

Business Description

Fundamentals

Charts & Quotes

STXS's News

Suppliers

STXS's Competitors

Customers & Markets

Economic Indicators

STXS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071